JAMDA
May 24, 2016
Showing 921 - 930 of 9013 results
Caring for the Ages
December 24, 2019
Antimicrobial Stewardship With a Collaborative Team
JAMDA
February 25, 2016
Antipsychotic and Other Psychotropic Medications in Special Care Dementia Units: Outcomes Using a Mini Behavior Rating Scale and Objective Medication Use Guideline
JAMDA
June 22, 2018
Antipsychotic Deprescription for Older Adults in Long-term Care: The HALT Study
Despite limited efficacy and significant safety concerns, antipsychotic medications are frequently used to treat behavioral and psychological symptoms of dementia (BPSD) in long-term residential care. This study evaluates the sustained reduction of antipsychotic use for BPSD through a deprescribing interve...
JAMDA
September 25, 2023
Antipsychotic Drug Reduction through the Implementation of a Neurologically Oriented, Interdisciplinary Psycho-Diagnostic and Antipsychotic Stewardship Program
Antipsychotic utilization in skilled nursing facilities (SNFs) is a major focus of regulatory compliance and a key theme in resident care. This created opportunities for innovations in clinical care of behavioral and psychological symptoms of dementia (BPSD). In a shared initiative with one of our SNF oper...
JAMDA
February 27, 2016
Antipsychotic Drug Use Is Not Associated With Long-Term Mortality Risk in Norwegian Nursing Home Patients
To assess the long-term mortality risk associated with antipsychotic drug (AP) use in nursing homes.
JAMDA
August 4, 2020
Antipsychotic Drugs and Hip Fracture: Associations Before and After the Initiation of Treatment
To study the association between antipsychotic drug treatment and hip fracture, before and after the initiation of treatment.
JAMDA
February 25, 2020
Antipsychotic Drugs, Fracture Risk, and Frailty in Older Patients
Caring for the Ages
April 4, 2023
Antipsychotic Prescribing Varies Widely Among States
Other Event
Jun 23, 2026 11:30 am - Jun 23, 2026 1:30 pm
Antipsychotic Stewardship in SNFs: Project PAUSE, the Updated Long-Stay Metric, Boxed Warnings, and the Consultant Pharmacist’s Essential Role in Regulatory Compliance and Resident-Centered Care
This APEX webinar delivers practical, up-to-date guidance on appropriate antipsychotic management, spotlighting the consultant pharmacist’s leadership role in balancing safety, regulatory requirements, and resident quality of life. Join us for an in-depth exploration of Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness), the national coalition — with ASCP as a key convener — that has driven national advocacy for evidence-based antipsychotic use in nursing homes.
Read More
